Monarch Medical Technologies, maker of EndoTool® Glucose Management System, is pleased to announce the establishment of its Clinical Advisory Board. Comprising experts and thought leaders from diverse medical disciplines, this board will play a pivotal role in guiding our mission ...

Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced an up to $5.0 million investment in privately-held Monarch Medical Technologies, LLC (Monarch) through the purchase of ...

Monarch Medical Technologies, maker of the EndoTool Glucose Management System, received FDA clearance for its enhanced software for the treatment of inpatient hyperglycemia using subcutaneous insulin. "EndoTool SubQ will help hospitals graduate from sliding-scale protocols which is inherently unsafe, and ...

Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, has earned ISO 13485:2016 certification for its quality management system from the independent certifying body, TÜV SÜD. The international quality standard containing multiple criteria for the ...

Mercyhealth, a multi-regional healthcare system serving northern Illinois and southern Wisconsin, is partnering with Monarch Medical Technologies to improve care for patients with diabetes or stress-induced hyperglycemia. Using Monarch's FDA-cleared insulin dosing software, EndoTool, Mercyhealth will be able to provide ...

The June 25th webinar to discuss best practices for initiating and managing insulin therapy across the continuum of care. Despite advances in treatment and clear guidelines, many patients with diabetes are failing to achieve target glucose levels both in the ...

June 10, 2019 An article published by MD Magazine (now HCPLive) explores the findings of a study on the correlation between late blood glucose checks and incidence of hypoglycemia, presented by Dr. Patrick Burgess at the American Diabetes Association Scientific ...

Monarch's EndoTool SubQ to feature optional insulin-on-board (IOB) calculation for subcutaneous insulin to mitigate the risk of hypoglycemia. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced U.S. Food and Drug Administration (FDA) ...

Monarch Medical Technologies, the leader in precision insulin dosing technology for optimized glycemic management, today announced it will be participating in two upcoming diabetes industry events, the DiabetesMine D-Data Exchange on June 7, 2019 and the American Diabetes Association 79th ...

Two posters presented at AACE 2019 review the safety and efficacy of blood glucose goal range and two-hour blood glucose checks for intravenous insulin dosing. Monarch Medical Technologies, the leader in precision insulin dosing technology for optimized glycemic management, presented ...

The March 6 webinar features Dr. Sandy Fogel of Carilion Clinic discussing glycemic management quality improvement in preparation for new quality metrics. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced that the ...

Monarch's new EndoTool Community provides clients the ability to collaborate, access resources and manage support requests. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced the launch of the EndoTool Community, a portal ...

The leader in electronic systems for inpatient glycemic management adds Dr. Mark Vanderwel as an adviser to support company in advancing diabetes management for pediatric patients. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, ...

January 13, 2019 An article published by Drs. Pedro Salinas and Carlos Mendez in the Journal of Diabetes Science and Technology explores the efficacy of technology solutions for glycemic care in the hospital setting, with a specific focus on the ...

October 23, 2018 An article published by Insulin Nation explores the past, present and future of automated insulin dosing, including various tools and algorithms used within the hospital setting and new developments such as CGM and insulin pumps for the ...

October 19, 2018 A blog post published by DiabetesMine explores why many hospitals still use an old-fashioned, time-consuming, error-prone approach to glucose management versus a technology-enabled approach like EndoTool, noting a big challenge is convincing hospital administration and providers this ...

Healthcare professionals from leading systems gather to share best practices using EndoTool IV and EndoTool SubQ across hospital units and patient populations. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced that they ...

New patent protects patient-specific methods and systems for safe subcutaneous and intravenous insulin dosing. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced the U.S. Patent and Trademark Office (USPTO) has issued a ...

Drs. Carlos Mendez and Brian Ulmer join roster of medical experts to support company in delivering individualized insulin dosing for improved inpatient diabetes management. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced ...

Providers can bridge the gap between inpatient and outpatient glycemic management with Monarch's EndoTool Glucose Management System and Voluntis' Insulia. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, and Voluntis (Euronext Paris: FRXX - ...

Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced that it has been selected by Modern Healthcare as one of the 2018 Best Places to Work in Healthcare. This is the second year ...

Presenter Jane Jeffrie Seley, Program Manager of Inpatient Glycemic Control Program at NewYork-Presbyterian Hospital/Weill Cornell Medicine, to focus on strategies to engage nursing staff in glycemic management practices. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient ...

April 13, 2018 An article published by ACP Hospitalist explores how recommended glucose targets remain elusive for many hospitals, but some have made inroads by leveraging the power of computerized systems to optimize insulin dosing. Read Here ...

February 19th, 2018 An article in Becker's Health IT & CIO Review explores why hospital medical errors continue to remain one of the leading causes of death in the United States, and how adoption of new technologies, such as an ...

Self-Service Analytics expands on current EndoTool Analytics offering, allowing clients to utilize existing business intelligence tools for advanced data mining. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced the launch of Self-Service ...

Presenters Dr. Thomas Garthwaite, VP of Diabetes Care at HCA, and Laurel Fuqua, EVP and CCO at Monarch, focus on strategies in optimizing glycemic management. Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today ...

EndoTool user community gathers in Charlotte to share best practices, innovations and industry trends for optimizing glycemic control of in-hospital patients. Monarch Medical Technologies, the leader in electronic glycemic management systems for in-hospital patients, today announced that they will be ...

Monarch Medical Technologies, the leader in electronic glycemic management systems (eGMS) for in-hospital patients, today announced that Laurel Fuqua, RN, MSN is joining the Monarch leadership team, as Executive Vice President and Chief Clinical Officer. In this role, Fuqua will ...

June 21, 2016 An article published by Diabetes Times explores a seven-year study on the use of a computer-guided glucose management system (EndoTool) and its impact on various quality metrics, such as hyperglycemia, hypoglycemia and time to control. Read Here ...

  Read Here ...

EndoTool from Monarch Medical Technologies reduces hypoglycemia rates and controls blood glucose levels. Vidant Medical Center, the flagship hospital for Vidant Health in Greenville, NC, is proud to present their poster demonstrating marked improvement in quality of care with patients ...

New technology from Monarch Medical Technologies statistically eliminates severe hypoglycemia in hospital glucose management. Monarch Medical Technologies, a company committed to providing the safest insulin dosing software, is proud to announce their EndoTool's groundbreaking, patent-pending Estimated Residual Extracellular Insulin (EREI) ...

The polls are in and the employees have been heard. Monarch Medical Technologies, the company committed to the safest insulin dosing software, today announces that the Charlotte Business Journal recognizes Monarch Medical Technologies on its annual list of "Best Places ...

EndoTool dosing recommendations applauded by hospitals. Monarch Medical Technologies, the safest provider of glucose management software, announces record growth and continues to shift the U.S. hospital market towards improved glucose management. In regards to insulin therapy treatment, studies show that ...

EndoTool SubQ utilizes clinically-proven and patent-pending model predictive control technology to determine the safest patient-specific basal/bolus and correction subcutaneous insulin dose recommendations. Monarch Medical Technologies, a medical technology company committed to safe insulin dosing, today announced that the US Food ...

Monarch Medical Technologies, the pioneer and leader in clinical decision support for drug dosing in hospitalized patients, today announced that it has developed a medical advisory board to counsel the company on strategic areas of interest. The board includes members ...

Next generation glucose management solution offers several new features to aid healthcare professionals in addressing the most complex cases. Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today ...

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, has earned ISO 13485:2003 certification for its quality management system from the independent certifying body, Nemko. The international quality standard ...

A late-breaking poster presented at the 73rd Scientific Sessions of the American Diabetes Association by Greenville, NC-based Vidant Medical Center, the flagship hospital for Vidant Health and the teaching hospital for the Brody School of Medicine at East Carolina University, ...

Company focused on helping hospitals and health systems mitigate risk associated with drugs and processes of concern. Palo Alto, Calif.-based private investment firm Eigen Capital LLC, which acquired the EndoTool business from Hospira Worldwide in September 2012, today unveiled the ...

November 30, 2009 An article published by US Endocrinology explores computer-guided glucose management systems as an alternative to paper protocols for critically ill patients requiring intravenous insulin. Read Here ...